NextCell Pharma at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

NextCell Pharma at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).

OrganizationBIO-Europe 2026 Attendance
nextcellpharma.com
Biotech
Swedish company developing ProTrans, an allogeneic stem cell therapy for type 1 diabetes.
Panel
Tue Nov 10
14:00–14:25
Future-proofing Manufacturing for Commercialization of Allogeneic Cell Therapies: From Phase II to Global Commercialization
How to prepare donor-derived cell therapies for global sale, from finalizing manufacturing after phase 2 to meeting regulators' rules and planning capacity.

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from NextCell Pharma

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction